Suresnes (France), December 4, 2025 – Servier, an independent international pharmaceutical company governed by a foundation, has entered into a research collaboration with University College London (UCL), a prestigious centuries-old British university and part of the University of London, to test candidate drugs from Servier in innovative patient-derived cell models known as brain assembloids, complex … Continue reading Servier and University College London join forces to advance therapeutic research in rare genetic epileptic disorders